logo
How the atomic bombing of Nagasaki tore apart Japan's understanding of motherhood

How the atomic bombing of Nagasaki tore apart Japan's understanding of motherhood

CNN5 days ago
EDITOR'S NOTE: This story is part of As Equals, CNN's ongoing series on gender inequality. For information about how the series is funded and more, check out our FAQs.
When Kikuyo Nakamura's adult son discovered bumps on his back, she assumed it was just a rash.
Still, she urged him to go to the hospital — better safe than sorry.
Hiroshi, her second son, was born in 1948, three years after the U.S. dropped an atomic bomb on Nagasaki. As a survivor of the bombing, Nakamura had long feared she might pass on health problems to her children.
In 2003, at age 55, Hiroshi went to the hospital. Two days passed without any word from him. Then three. Then a week.
Eventually Nakamura went to the hospital, where her son told her: ''They're going to do more tests,' she told CNN.
The results showed he had stage 4 leukemia –– an advanced stage of blood cancer that had spread to other parts of his body. According to Nakamura, the doctor told her that she had given her son cancer –– suggesting the radiation that caused it was passed on through breastfeeding when he was a baby.
When Hiroshi died, six months later, his mother was left to believe she had essentially killed him; a thought that still haunts her more than two decades on.
'I was overwhelmed with guilt and suffering… Even now, I still believe what the doctor said, that I caused it. That guilt still lives in me,' said Nakamura, who is now 101-years old.
Those who are exposed to nuclear radiation are generally urged to stop breastfeeding in the immediate aftermath of an atomic blast. But experts say there's no concrete evidence that first generation 'hibakusha' –– atomic bomb survivors of World War II –– can pass cancer-causing material to their children, years after exposure.
As the 80th anniversary of the US bombings of Hiroshima and Nagasaki approaches, aging survivors — some, like Nakamura, more than 100-years old — are sharing their stories of suffering and resilience, while they still can.
Many of them were young women, either pregnant or of childbearing age, when the bombs fell and have lived much of their lives under a heavy shadow of fear and stigma.
They were told by medical practitioners, neighbors, even friends and family that their exposure to nuclear radiation could cause them to have children with illnesses or disabilities –– if they conceived at all.
Even when infertility or a child's disability had nothing to do with radiation exposure, hibakusha women often felt blamed and shunned.
Those with visible scars from the blasts faced barriers to marriage. Physical wounds were harder to hide — and clearer proof of exposure.
And at a time in society when a woman's worth was closely tied to marriage and motherhood, this stigma was particularly damaging.
It caused a large number of women survivors –– many of whom had PTSD (post-traumatic stress disorder) –– to 'hide the fact that they were hibakusha,' according to Masahiro Nakashima, a professor of radiation studies at Nagasaki University.
'In a society like Japan — where gender discrimination and male dominance have been deeply rooted — women were especially affected by radiation,' Nakashima told CNN.
Radiation exposure did affect some second-generation survivors, depending on the timing of pregnancy.
The embryonic period — generally ranging from weeks 5 up to 15 — is especially sensitive for brain and organ development. Women exposed to radiation during this window had a higher risk of giving birth to children with intellectual disabilities, neurological issues, and microcephaly, a condition marked by a small head and impaired brain function, according to studies from the joint Japan-US Radiation Effects Research Foundation (RERF) –– a successor to the Atomic Bomb Casualty Commission formed just after World War II.
Other studies showed that women hibakusha faced long-term health risks themselves.
A 2012 RERF study found that radiation exposure from an atomic bomb raised cancer risk for the rest of a person's life. Solid cancer rates for women at age 70 increased by 58 percent for every gray of radiation their bodies absorbed at age 30. A gray is a unit that measures how much radiation energy a body or object takes in. For men, solid cancer rates increased by 35 percent.
Nakamura was 21-years old and was hanging laundry outside around 11am when the bomb fell on Nagasaki on August 9, 1945. She says she was 5 kilometers (3.1 miles) from the epicenter –– a little beyond what experts call the area of 'total destruction.'
The young mother saw a bright light, followed by a loud boom and a powerful gust of wind that flung her into the air. When she regained consciousness, her house was wrecked — furniture was strewn everywhere and glass shards covered the floor. She called out to her own mother, who had been helping Nakamura care for her eldest son.
Relieved they weren't physically wounded, the family fled to an air raid shelter. It wasn't until the next day that Nakamura grasped the scale of destruction. Relatives living near Nagasaki University, closer to the blast, all died.
Nakamura says she didn't suffer any effects of radiation exposure. She had her uterus removed four years later, and at age 70, doctors found a tumor in her abdomen, but her physicians told her neither issue was linked to the bombing, she said.
The psychological trauma, however, has stayed with her ever since.
Ashamed of her own exposure, she feared the stigma would also pass to her grandchildren.
'If people knew that my son died of leukemia, especially before they (my grandchildren) got married, others might not want to marry them. I made sure my children understood that. We kept it within the family and didn't tell anyone else about how he died,' Nakamura said.
But encouraged by other survivors, she finally spoke publicly about her son's cancer in 2006, three years after his death.
'I received phone calls and even letters from people who heard my story. It made me realize how serious the issue of inherited health effects is in Hiroshima and Nagasaki,' she said.
Even though she now knows it's unlikely she could have caused her son's cancer, she says as a mother, the feeling of guilt is a burden she'll forever carry.
'I still feel so sorry. I keep apologizing to him. I say, 'Forgive me,'' she said.
The unique burden of hibakusha motherhood is something Mitsuko Yoshimura, now 102-years old, never got to carry.
Separated from her parents and sister at a young age, she always longed for a family. She moved to Nagasaki for a good job in Mitsubishi's payroll department — just months before the US dropped the bomb, turning the city into hell on earth.
'When I got out to the road, there were people with blood gushing from their heads, people with the skin peeled off their backs,' she recalled.
Being just a kilometer (0.6 miles) away from the epicenter of the blast, her survival was nothing short of a miracle. In the months that followed, she stayed behind to help the injured. But her body suffered too.
'My hair fell out. Whenever I tried to comb it with my hands, strands would come out little by little,' Yoshimura said. She also regularly vomited blood for months after the blast.
Still, she endured. She got married a year after the war ended. Her husband was an atomic bomb survivor, like herself, and their marriage marked a fresh start for the couple.
But the child they longed for never followed. She had two miscarriages and a stillbirth.
Yoshimura lives alone now; her husband having died years ago. In her home in Nagasaki, where photos of children and grandchildren might be, there are dolls — a quiet substitute for what was lost, she said.
At their remarkable age, Nakamura and Yoshimura both know they don't have much longer to live. But that gives them greater urgency to educate younger generations about the toll of nuclear war.
'People really need to think carefully. What does winning or losing even bring? Wanting to expand a country's territory, wanting a country to gain more power, what exactly are people seeking from that?' Nakamura asked.
'I don't understand it. But what I do feel deeply is the utter foolishness of war,' she said.
Reporter
Hanako Montgomery
Editors
Sheena McKenzie, Todd Symons
Producer
Junko Ogura
Senior Video Producer
Ladan Anoushfar
Visual Editor
Carlotta Dotto
Video Editor
Estefania Rodriguez, Daishi Kusunoki
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Could Consumption of UPFs Up Lung Cancer Risk?
Could Consumption of UPFs Up Lung Cancer Risk?

Medscape

time3 hours ago

  • Medscape

Could Consumption of UPFs Up Lung Cancer Risk?

Individuals who ate more ultra-processed foods (UPFs) had a significantly higher risk for lung cancer over 12 years than those who ate fewer UPFs, based on new data from more than 100,000 adults in an observational study. Cigarette smoking is a known contributor to lung cancer, but diet also is known to play a role; however, data on the impact of UPFs in particular on lung cancer risk remain unclear, Kanran Wang, MD, of Chongqing Cancer Hospital, Chongqing, China, and colleagues wrote. In a study published in Thorax, the researchers reviewed data from 101,732 adults enrolled in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, a randomized trial of screening tests for lung, prostate, colorectal, and ovarian cancers from 10 centers across the US. The primary endpoint was the incidence of lung cancer. In a multivariate analysis, individuals in the highest quartile of UPF consumption were 41% more likely to develop lung cancer than those in the lowest quartile of consumption (hazard ratio [HR], 1.41); risk also was higher for both non-small cell lung cancer (NSCLC) (HR, 1.37) and small cell lung cancer (SCLC) (HR, 1.44). These results remained statistically significant after a large range of subgroup and sensitivity analyses, including age, sex, and family history of lung cancer. UPF consumption was based on the Food Frequency Questionnaire, and foods were classified by dietitians into four categories of processing as unprocessed or minimally processed, processed culinary ingredients, processed foods, and UPF, based on the NOVA criteria. The mean age of the study population at baseline was 62.5 years. The mean energy-adjusted UPF consumption was 2.8 servings/d, with mean servings for the lowest and highest intake quarters of 0.5 and 6.0, respectively. Approximately half of the participants in each quarter were current or ever-smokers. The researchers identified 1706 lung cancer cases over a mean follow-up of 12.2 years, including 1473 cases of NSCLC and 233 cases of SCLC. Potential explanations for the association between UPF and lung cancer include the impact of nutritional components of UPF including high sodium, saturated fats, added sugar, and low fiber, the researchers noted. Overall, lunchmeat was the greatest contributor to UPF (11%) following by caffeinated soft drinks (diet and regular) and decaffeinated soft drinks (diet and regular), which each accounted for approximately 7% of UPF intake. The researchers acknowledged the study limitations, including the observational design, limited number of incident events, relatively homogenous study population, and use of self-reports. However, they concluded that if the findings are confirmed in other studies, limiting trends of UPF intake globally could help reduce the overall burden of lung cancer. In addition, 'future studies should elucidate potential molecular mechanisms and increase understanding of the observed associations,' the researchers wrote. Caveats Abound, Experts Say Several experts weighed in with comments that were published online in the Science Media Centre. Although the study was well-conducted, limitations include the study population of only adults aged 55-74 years in the US, therefore the results may not be relevant to younger individuals in other countries, said Rachel Richardson, acting head of methods support, The Cochrane Collaboration, in an editorial section accompanying the study. In addition, dietary habits also change considerably over the course of long-term studies; therefore, 'it is difficult to directly conclude that lung cancer is related to the level of UPF consumption alone given it was only declared at the start of the study,' wrote Sam Hare, MD, a consultant chest radiologist at Royal Free London NHD Trust. 'The most obvious confounding factor here is smoking, which is well-known to cause a greatly increased risk of lung cancer,' wrote Adam Jacobs, MD, executive director and strategic consultant, biostatistics, Ergomed. 'If people with high UPF consumption smoked more than people with low UPF consumption, then that difference in smoking could easily lead to the observed results,' he said. The researchers' efforts to adjust for smoking was limited by the use of only two categories (current/former smokers and nonsmokers) and the use of self-reports, he said. Study Has Merit, but More Work Is Needed There was ample justification to conduct a study on the link between UPF and lung cancer, as prior evidence on this association was limited and inconsistent, said Jamie Garfield, MD, professor of thoracic medicine and surgery at the Lewis Katz School of Medicine at Temple University, Philadelphia, in an interview. 'Given the global rise in UPF consumption and the high burden of lung cancer, clarifying this relationship is important for public health and cancer prevention strategies,' said Garfield, who was not involved in the study. Strengths of this study include the large, well-characterized population, pathologic confirmation of lung cancer, and comprehensive adjustment for confounders such as smoking, diet quality, and demographic factors, she said. The findings of a statistically significant association between higher UPF intake and increased risk for lung cancer (including both NSCLC and SCLC), were not surprising, as similar associations have been observed for other cancer types and chronic diseases, Garfield told Medscape Medical News . 'However, the magnitude and consistency of the association across subgroups, and the observation that the risk persisted after adjustment for smoking and diet quality, are notable and reinforce the plausibility of a direct link,' she said. The findings were limited by the observational design that prevents conclusions of causality, especially from unmeasured smoking intensity, said Garfield. Additionally, the single dietary assessment at baseline only may not capture dietary changes over time and could lead to misclassification of UPF intake bias, she noted. Other limitations included the use of a validated food frequency questionnaire not designed to align with the NOVA classifications, and the use of a mainly non-Hispanic White study population, Garfield said. Despite the limitations, the study findings are worthwhile and have potential implications for clinical practice, Garfield told Medscape Medical News . 'They support dietary counseling to limit UPF intake as part of cancer prevention,' she said. However, 'Further research in more diverse populations and with repeated dietary measures is needed to confirm causality and clarify mechanisms,' she added. This study was funded by the Chongqing University Cancer Hospital, Chongqing, China, and received grants from the Chongqing Talent Plan, Chongqing Shapingba District Technological Innovation Project. The researchers disclosed no financial conflicts of interest. The Science Media Centre commentators disclosed no financial conflicts of interest.

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry
Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Yahoo

time5 hours ago

  • Yahoo

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

By Rishika Sadam and Kashish Tandon (Reuters) -Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping up competition with Novo Nordisk. Lilly said in June it received approval from India's drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo Nordisk launched Wegovy in multiple dose strengths in a similar pen device. Mounjaro Kwikpen is available in six dose strengths — 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg — with pricing calculated for a month's supply. The smallest two doses are priced at 14,000 and 17,500 rupees, respectively, and the 7.5 mg and 10 mg doses cost 22,000 rupees. The 12.5 mg and 15 mg doses cost 27,500 rupees, the company said. "If we look at how the highest doses of Mounjaro and Wegovy are priced, it appears (that) Mounjaro's pricing is attractive and competitive," said Vishal Manchanda from Systematix Institutional Equities. Wegovy's smallest doses of 0.25 mg, 0.5 mg and 1 mg cost 17,345 rupees a month, and its highest doses of 1.7 mg and 2.4 mg cost 24,280 rupees and 26,015 rupees a month, respectively. Lilly began selling Mounjaro in India in late March for diabetes and obesity in 2.5 mg and 5 mg vials. Both drugs have seen strong demand since then, with sales in July doubling month-on-month. The drugs belong to a class of therapies known as GLP-1 receptor agonists that help control blood sugar and slow digestion, making people feel fuller for longer. ($1 = 87.6650 Indian rupees)

Using AI to Track and Treat Allergies
Using AI to Track and Treat Allergies

Bloomberg

time5 hours ago

  • Bloomberg

Using AI to Track and Treat Allergies

Hi, it's Karoline in Singapore, where hay fever is very common. Now a new AI-driven program led by a public hospital here is trying to build a database to better understand the condition. But before I tell you how and why ... I have hay fever, also known as allergic rhinitis, and am not always sure whether or not I should see a doctor, because my symptoms can be hard to predict. One morning, they could be too minor to bother a doctor, but turn very bad the next, with my breathing strained. I wish there was a doctor near me available 24 hours a day to prescribe medication or give me a treatment plan.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store